Identification of ABCC5 Among ATP-Binding Cassette Transporter Family as a New Biomarker for Hepatocellular Carcinoma Based on Bioinformatics Analysis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address: [email protected]. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
   PubMed Web of Science ®Google Scholar
• Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477–491.e1. doi:10.1053/j.gastro.2018.08.065
   PubMed Web of Science ®Google Scholar
• Uzunlulu M, Telci Caklili O, Oguz A. Association between metabolic syndrome and cancer. Ann Nutr Metab. 2016;68(3):173–179. doi:10.1159/000443743
   PubMed Web of Science ®Google Scholar
• Piñero F, Dirchwolf M, Pessôa MG. Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment. Cells. 2020;9(6):1370. doi:10.3390/cells9061370
   PubMed Web of Science ®Google Scholar
• Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res. 2001;42(7):1007–1017. doi:10.1016/S0022-2275(20)31588-1
   PubMed Web of Science ®Google Scholar
• Vasiliou V, Vasiliou K, Nebert DW. Human ATP-binding cassette (ABC) transporter family. Hum Genomics. 2009;3(3):281–290. doi:10.1186/1479-7364-3-3-281
   PubMedGoogle Scholar
• Meng X, Clews J, Martin ER, et al. The structural basis of cystic fibrosis. Biochem Soc Trans. 2018;46(5):1093–1098. doi:10.1042/BST20180296
   PubMed Web of Science ®Google Scholar
• Lenis TL, Hu J, Ng SY, et al. Expression of ABCA4 in the retinal pigment epithelium and its implications for stargardt macular degeneration. Proc Natl Acad Sci U S A. 2018;115(47):E11120–E11127. doi:10.1073/pnas.1802519115
   PubMed Web of Science ®Google Scholar
• Li LT, Li ZD, Yang Y, et al. ABCB11 deficiency presenting as transient neonatal cholestasis: correlation with genotypes and BSEP expression. Liver Int. 2020;40(11):2788–2796. doi:10.1111/liv.14642
   PubMed Web of Science ®Google Scholar
• Liu X. ABC family transporters. Adv Exp Med Biol. 2019;1141:13–100.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang X, Li J, et al. Systematic analysis of the ABC transporter family in hepatocellular carcinoma reveals the importance of ABCB6 in regulating ferroptosis. Life Sci. 2020;257:118131. doi:10.1016/j.lfs.2020.118131
   PubMed Web of Science ®Google Scholar
• Pasello M, Giudice AM, Scotlandi K. The ABC subfamily A transporters: multifaceted players with incipient potentialities in cancer. Semin Cancer Biol. 2020;60:57–71. doi:10.1016/j.semcancer.2019.10.004
   PubMed Web of Science ®Google Scholar
• Gu X, Manautou JE. Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metab Rev. 2010;42(3):482–538. doi:10.3109/03602531003654915
   PubMed Web of Science ®Google Scholar
• Liu X. Transporter-mediated drug-drug interactions and their significance. Adv Exp Med Biol. 2019;1141:241–291.
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1–6. doi:10.1016/S1476-5586(04)80047-2
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.211
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1. doi:10.1126/scisignal.2004088
   PubMed Web of Science ®Google Scholar
• Gil-Martins E, Barbosa DJ, Silva V, et al. Dysfunction of ABC transporters at the blood-brain barrier: role in neurological disorders. Pharmacol Ther. 2020;213:107554.
   PubMed Web of Science ®Google Scholar
• Chen Z, Shi T, Zhang L, et al. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett. 2016;370(1):153–164. doi:10.1016/j.canlet.2015.10.010
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
   PubMed Web of Science ®Google Scholar
• De Franco E, Saint-Martin C, Brusgaard K, et al. Update of variants identified in the pancreatic β-cell KATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes. Hum Mutat. 2020;41(5):884–905. doi:10.1002/humu.23995
   PubMed Web of Science ®Google Scholar
• Wurmbach E, Chen YB, Khitrov G, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology. 2007;45(4):938–947. doi:10.1002/hep.21622
   PubMed Web of Science ®Google Scholar
• Girardi E, César-Razquin A, Lindinger S, et al. A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs. Nat Chem Biol. 2020;16(4):469–478. doi:10.1038/s41589-020-0483-3
   PubMed Web of Science ®Google Scholar
• Jetter A, Kullak-Ublick GA. Drugs and hepatic transporters: a review. Pharmacol Res. 2020;154:104234. doi:10.1016/j.phrs.2019.04.018
   PubMed Web of Science ®Google Scholar
• Icard P, Shulman S, Farhat D, et al. How the warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat. 2018;38:1–11. doi:10.1016/j.drup.2018.03.001
   PubMed Web of Science ®Google Scholar
• Reczek CR, Birsoy K, Kong H, et al. A CRISPR screen identifies a pathway required for paraquat-induced cell death. Nat Chem Biol. 2017;13(12):1274–1279. doi:10.1038/nchembio.2499
   PubMed Web of Science ®Google Scholar
• Flegel WA, Srivastava K, Sissung TM, et al. Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes. Vox Sang. 2021;116(2):141–154. doi:10.1111/vox.12999
   PubMed Web of Science ®Google Scholar
• Theodoulou FL, Kerr ID. ABC transporter research: going strong 40 years on. Biochem Soc Trans. 2015;43(5):1033–1040. doi:10.1042/BST20150139
   PubMed Web of Science ®Google Scholar
• Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111–128. doi:10.1038/nrgastro.2017.119
   PubMed Web of Science ®Google Scholar
• Tian Z, Hou X, Liu W, et al. Macrophages and hepatocellular carcinoma. Cell Biosci. 2019;9(1):79. doi:10.1186/s13578-019-0342-7
   PubMed Web of Science ®Google Scholar
• Yao -R-R, Li J-H, Zhang R, et al. M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway. World J Surg Oncol. 2018;16(1):9. doi:10.1186/s12957-018-1312-y
   PubMed Web of Science ®Google Scholar
• Peng ZP, Jiang ZZ, Guo HF, et al. Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma. J Hepatol. 2020;73(4):906–917. doi:10.1016/j.jhep.2020.05.004
   PubMed Web of Science ®Google Scholar
• Lurje I, Hammerich L, Tacke F. Dendritic cell and T cell crosstalk in liver fibrogenesis and hepatocarcinogenesis: implications for prevention and therapy of liver cancer. Int J Mol Sci. 2020;21(19):7378. doi:10.3390/ijms21197378
   PubMed Web of Science ®Google Scholar
• Cao J, Kong F-H, Liu X, et al. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: a meta-analysis. World J Gastroenterol. 2019;25(27):3649–3663. doi:10.3748/wjg.v25.i27.3649
   PubMed Web of Science ®Google Scholar
• Chao Y, Zhou D. lncRNA-D16366 is a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma. Med Sci Monit. 2019;25:6581–6586. doi:10.12659/MSM.915100
   PubMed Web of Science ®Google Scholar
• Song D, Wang Y, Zhu K, et al. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. World J Surg Oncol. 2020;18(1):176. doi:10.1186/s12957-020-01953-1
   PubMed Web of Science ®Google Scholar
• Zhou C, Li R, Mi W. circ_0067934: a potential biomarker and therapeutic target for hepatocellular carcinoma. Ann Clin Lab Sci. 2020;50(6):734–738.
   PubMed Web of Science ®Google Scholar